|
HNRNPH2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.95870053088765E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63258295771129E-12 |
| Normal-vs-Stage2 |
1.639320E-03 |
| Normal-vs-Stage3 |
1.79501999999498E-05 |
| Normal-vs-Stage4 |
1.96570004717955E-09 |
| Stage1-vs-Stage2 |
3.002000E-01 |
| Stage1-vs-Stage3 |
1.586400E-01 |
| Stage1-vs-Stage4 |
3.180800E-01 |
| Stage2-vs-Stage3 |
9.100200E-01 |
| Stage2-vs-Stage4 |
1.074010E-01 |
| Stage3-vs-Stage4 |
6.437700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.21884749357559E-14 |
| Normal-vs-AfricanAmerican |
8.10440003995438E-09 |
| Normal-vs-Asian |
2.474300E-02 |
| Caucasian-vs-AfricanAmerican |
4.304000E-01 |
| Caucasian-vs-Asian |
6.787600E-01 |
| AfricanAmerican-vs-Asian |
5.535200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.33226762955019E-15 |
| Normal-vs-Female |
1.65402999999786E-05 |
| Male-vs-Female |
1.560580E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.88899995645642E-09 |
| Normal-vs-Extreme_Weight |
1.62758695410048E-12 |
| Normal-vs-Obese |
2.46970000006286E-08 |
| Normal-vs-Extreme_Obese |
1.10529999997055E-06 |
| Normal_Weight-vs-Extreme_Weight |
3.208200E-01 |
| Normal_Weight-vs-Obese |
3.720400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.536600E-01 |
| Extreme_Weight-vs-Obese |
3.342500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.991800E-01 |
| Obese-vs-Extreme_Obese |
5.623000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.36689999999484E-05 |
| Normal-vs-Age(41-60Yrs) |
4.1314729415376E-12 |
| Normal-vs-Age(61-80Yrs) |
5.6621374255883E-15 |
| Normal-vs-Age(81-100Yrs) |
1.52120000040945E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.865200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.156200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.309000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.073170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.777800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.950600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62836411021772E-12 |
| Normal-VS-Type2 PRCC |
1.06709974190267E-10 |
| Normal-VS-KIRP CIMP |
9.54690000000147E-05 |
| Normal-VS-Unclassified PRCC |
2.67940000187039E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.534400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.044800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.345630E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.558800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.840200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.920200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.29105623361647E-12 |
| Normal-vs-N1 |
6.973000E-04 |
| Normal-vs-N2 |
4.721600E-03 |
| N0-vs-N1 |
4.803600E-02 |
| N0-vs-N2 |
3.500800E-01 |
| N1-vs-N2 |
9.215200E-01 |
|
|
